675 related articles for article (PubMed ID: 15039386)
61. Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire.
Mathey E; Breithaupt C; Schubart AS; Linington C
Eur J Immunol; 2004 Aug; 34(8):2065-71. PubMed ID: 15259003
[TBL] [Abstract][Full Text] [Related]
62. Oligoclonal IgG bands synthesized in the central nervous system are present in rats with experimental autoimmune encephalomyelitis.
Rostrom B; Grubb A; Holmdahl R
Acta Neurol Scand; 2004 Feb; 109(2):106-12. PubMed ID: 14705972
[TBL] [Abstract][Full Text] [Related]
63. Antibodies directed against rubella virus induce demyelination in aggregating rat brain cell cultures.
Besson Duvanel C; Honegger P; Matthieu JM
J Neurosci Res; 2001 Sep; 65(5):446-54. PubMed ID: 11536329
[TBL] [Abstract][Full Text] [Related]
64. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
Belogurov AA; Kurkova IN; Friboulet A; Thomas D; Misikov VK; Zakharova MY; Suchkov SV; Kotov SV; Alehin AI; Avalle B; Souslova EA; Morse HC; Gabibov AG; Ponomarenko NA
J Immunol; 2008 Jan; 180(2):1258-67. PubMed ID: 18178866
[TBL] [Abstract][Full Text] [Related]
65. Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.
von Büdingen HC; Tanuma N; Villoslada P; Ouallet JC; Hauser SL; Genain CP
J Clin Immunol; 2001 May; 21(3):155-70. PubMed ID: 11403222
[TBL] [Abstract][Full Text] [Related]
66. [Diagnostic value of antibodies to myelin oligodendrocyte glycoprotein in demyelinating diseases of the central nervous system].
Shchepareva ME; Kochergin IA; Tolpeeva OA; Shabalina AA; Zakharova MN
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(2. Vyp. 2):18-23. PubMed ID: 31156236
[TBL] [Abstract][Full Text] [Related]
67. Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis.
Van Haren K; Tomooka BH; Kidd BA; Banwell B; Bar-Or A; Chitnis T; Tenembaum SN; Pohl D; Rostasy K; Dale RC; O'Connor KC; Hafler DA; Steinman L; Robinson WH
Mult Scler; 2013 Nov; 19(13):1726-33. PubMed ID: 23612879
[TBL] [Abstract][Full Text] [Related]
68. Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.
Elong Ngono A; Lepetit M; Reindl M; Garcia A; Guillot F; Genty A; Chesneau M; Salou M; Michel L; Lefrere F; Schanda K; Imbert-Marcille BM; Degauque N; Nicot A; Brouard S; Laplaud DA; Soulillou JP
J Immunol Res; 2015; 2015():673503. PubMed ID: 26090495
[TBL] [Abstract][Full Text] [Related]
69. In vitro evidence that immunuaffinity-purified MOG contains immunogenic quantities of contaminating mouse IgG; techniques for producing Ig-free MOG.
Ohashi T; Yukitake M; Slavin A; Krieger J; Hafler DA
J Neuroimmunol; 2001 Aug; 118(2):194-202. PubMed ID: 11498254
[TBL] [Abstract][Full Text] [Related]
70. Intrathecal synthesis of anti-myelin basic protein IgG in HIV-1+ patients.
Maimone D; Annunziata P; Cioni C; Leonardi A; Guazzi GC
Acta Neurol Scand; 1994 Oct; 90(4):285-92. PubMed ID: 7530889
[TBL] [Abstract][Full Text] [Related]
71. Intrathecal synthesis in particular types of multiple sclerosis.
Sladkova V; Mares J; Hlustik P; Langova J; Kanovsky P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):124-6. PubMed ID: 23073520
[TBL] [Abstract][Full Text] [Related]
72. Antigen microarrays identify CNS-produced autoantibodies in RRMS.
Quintana FJ; Farez MF; Izquierdo G; Lucas M; Cohen IR; Weiner HL
Neurology; 2012 Feb; 78(8):532-9. PubMed ID: 22262743
[TBL] [Abstract][Full Text] [Related]
73. Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
Pacini G; Ieronymaki M; Nuti F; Sabatino G; Larregola M; Aharoni R; Papini AM; Rovero P
J Pept Sci; 2016 Jan; 22(1):52-8. PubMed ID: 26663200
[TBL] [Abstract][Full Text] [Related]
74. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats.
Sakuma H; Kohyama K; Park IK; Miyakoshi A; Tanuma N; Matsumoto Y
Brain; 2004 Oct; 127(Pt 10):2201-13. PubMed ID: 15282218
[TBL] [Abstract][Full Text] [Related]
75. MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.
Jarius S; Ruprecht K; Stellmann JP; Huss A; Ayzenberg I; Willing A; Trebst C; Pawlitzki M; Abdelhak A; Grüter T; Leypoldt F; Haas J; Kleiter I; Tumani H; Fechner K; Reindl M; Paul F; Wildemann B
J Neuroinflammation; 2018 Mar; 15(1):88. PubMed ID: 29554927
[TBL] [Abstract][Full Text] [Related]
76. Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosis.
Schmidt S; Haase CG; Bezman L; Moser H; Schmidt M; Köhler W; Linington C; Klockgether T
J Neuroimmunol; 2001 Sep; 119(1):88-94. PubMed ID: 11525804
[TBL] [Abstract][Full Text] [Related]
77. Lack of association between antimyelin antibodies and progression to multiple sclerosis.
Kuhle J; Pohl C; Mehling M; Edan G; Freedman MS; Hartung HP; Polman CH; Miller DH; Montalban X; Barkhof F; Bauer L; Dahms S; Lindberg R; Kappos L; Sandbrink R
N Engl J Med; 2007 Jan; 356(4):371-8. PubMed ID: 17251533
[TBL] [Abstract][Full Text] [Related]
78. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T
J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963
[TBL] [Abstract][Full Text] [Related]
79. Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA.
Menge T; von Büdingen HC; Lalive PH; Genain CP
Eur J Immunol; 2007 Nov; 37(11):3229-39. PubMed ID: 17918203
[TBL] [Abstract][Full Text] [Related]
80. Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity.
Hellings N; Gelin G; Medaer R; Bruckers L; Palmers Y; Raus J; Stinissen P
J Neuroimmunol; 2002 May; 126(1-2):143-60. PubMed ID: 12020966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
